The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
Open accessAbstract
Progressive loss of T cell functionality is a hallmark of chronic infection with human immunodeficiency virus 1 (HIV-1). We have identified a novel population of dysfunctional T cells marked by surface expression of the glycoprotein Tim-3. The frequency of this population was increased in HIV-1–infected individuals to a mean of 49.4 ± SD 12.9% of CD8+ T cells expressing Tim-3 in HIV-1–infected chronic progressors versus 28.5 ± 6.8% in HIV-1–uninfected individuals. Levels of Tim-3 expression on T cells from HIV-1–infected inviduals correlated positively with HIV-1 viral load and CD38 expression and inversely with CD4+ T cell count. In progressive HIV-1 infection, Tim-3 expression was up-regulated on HIV-1–specific CD8+ T cells. Tim-3–expressing T cells failed to produce cytokine or proliferate in response to antigen and exhibited impaired Stat5, Erk1/2, and p38 signaling. Blocking the Tim-3 signaling pathway restored proliferation and enhanced cytokine production in HIV-1–specific T cells. Thus, Tim-3 represents a novel target for the therapeutic reversal of HIV-1–associated T cell dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., & Stein, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1710 · Cited by 4,173
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., et al. (1999) · Science · doi:10.1126/science.283.5403.857 · Cited by 2,187
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,835
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,571
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,472
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383
Self-citationBrenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073
Skewed maturation of memory HIV-specific CD8 T lymphocytes
Champagne, P., Ogg, G. S., King, A. S., Knabenhans, C., Ellefsen, K., Nobile, M., Appay, V., Rizzardi, G. P., Fleury, S., Lipp, M., et al. (2001) · Nature · doi:10.1038/35065118 · Cited by 1,004
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L., Schacker, T., Roederer, M., Douek, D. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061496 · Cited by 889
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function
Appay, V., Nixon, D. F., Donahoe, S. M., Gillespie, G. M. A., Dong, T., King, A., Ogg, G. S., Spiegel, H. M. L., Conlon, C., Spina, C. A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.63 · Cited by 871
Self-citationHunt, P. W., Martin, J. N., Sinclair, E., Bredt, B., Hagos, E., Lampiris, H., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Pitcher, C. J., Quittner, C., Peterson, D. M., Connors, M., Koup, R. A., Maino, V. C., & Picker, L. J. (1999) · Nature Medicine · doi:10.1038/8400 · Cited by 746
Lane, H. C., Depper, J. M., Greene, W. C., Whalen, G., Waldmann, T. A., & Fauci, A. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507113130204 · Cited by 728
Sánchez-Fueyo, A., Tian, J., Picarella, D., Domenig, C., Zheng, X. X., Sabatos, C. A., Manlongat, N., Bender, O., Kamradt, T., Kuchroo, V. K., et al. (2003) · Nature Immunology · doi:10.1038/ni987 · Cited by 712
Promotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells
Anderson, A. C., Anderson, D. E., Bregoli, L., Hastings, W. D., Kassam, N., Lei, C., Chandwaskar, R., Karman, J., Su, E. W., Hirashima, M., et al. (2007) · Science · doi:10.1126/science.1148536 · Cited by 701
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
Price, D. A., Goulder, P. J. R., Klenerman, P., Sewell, A. K., Easterbrook, P. J., Troop, M., Bangham, C. R. M., & Phillips, R. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1890 · Cited by 688
Hunt, P. W., Brenchley, J., Sinclair, E., McCune, J. M., Roland, M., Page‐Shafer, K., Hsue, P., Emu, B., Krone, M., Lampiris, H., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/524143 · Cited by 638
Self-citationSabatos, C. A., Chakravarti, S., Cha, E., Schubart, A., Sánchez-Fueyo, A., Zheng, X. X., Coyle, A. J., Strom, T. B., Freeman, G. J., & Kuchroo, V. K. (2003) · Nature Immunology · doi:10.1038/ni988 · Cited by 628
Liu, Z., Cumberland, W. G., Hultin, L. E., Prince, H. E., Detels, R., & Giorgi, J. V. (1997) · Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology · doi:10.1097/00042560-199710010-00003 · Cited by 546
Giorgi, J. V., Liu, Z., Hultin, L. E., Cumberland, W. G., Hennessey, K. A., & Detels, R. (1993) · PubMed · Cited by 443
Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade
Freeman, G. J., Wherry, E. J., Ahmed, R., & Sharpe, A. H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061800 · Cited by 399
Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen
Sachsenberg, N., Perelson, A. S., Yerly, S., Schockmel, G. A., Leduc, D., Hirschel, B., & Perrin, L. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1295 · Cited by 329
Shankar, P., Russo, M., Harnisch, B., Patterson, M., Skolnik, P., & Lieberman, J. (2000) · Blood · doi:10.1182/blood.v96.9.3094 · Cited by 285
Streeck, H., Brumme, Z. L., Anastario, M., Cohen, K. W., Jolin, J. S., Meier, A., Brumme, C. J., Rosenberg, E. S., Alter, G., Allen, T. M., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050100 · Cited by 243
Dysregulated T cell expression of TIM3 in multiple sclerosis
Koguchi, K., Anderson, D. E., Yang, L., O'Connor, K. C., Kuchroo, V. K., & Hafler, D. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060210 · Cited by 232
Emu, B., Sinclair, E., Favre, D., Moretto, W. J., Hsue, P., Hoh, R., Martin, J. N., Nixon, D. F., McCune, J. M., & Deeks, S. G. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14169-14178.2005 · Cited by 215
Self-citationZhang, D., Shankar, P., Xu, Z., Harnisch, B., Chen, G., Lange, C., Lee, S. J., Valdez, H., Lederman, M. M., & Lieberman, J. (2003) · Blood · doi:10.1182/blood-2002-03-0791 · Cited by 189
Kostense, S., Vandenberghe, K., Joling, J., Van Baarle, D., Nanlohy, N., Manting, E., & Miedema, F. (2002) · Blood · doi:10.1182/blood.v99.7.2505 · Cited by 183
Petrovas, C., Price, D. A., Mattapallil, J., Ambrozak, D. R., Geldmacher, C., Cecchinato, V., Vaccari, M., Tryniszewska, E., Gostick, E., Roederer, M., et al. (2007) · Blood · doi:10.1182/blood-2007-01-069112 · Cited by 173
Trimble, L. A., & Lieberman, J. (1998) · Blood · doi:10.1182/blood.v91.2.585 · Cited by 161
CD8+ T Cells Become Nonresponsive (Anergic) Following Activation in the Presence of Costimulation
Deeths, M. J., Kedl, R. M., & Mescher, M. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.102 · Cited by 156
Positivity of the Proliferation Marker Ki-67 in Noncycling Cells
van Oijen, M. G. C. T., Medema, R. H., Slootweg, P. J., et al. (1998) · American Journal of Clinical Pathology · doi:10.1093/ajcp/110.1.24 · Cited by 147
Lack of TIM-3 Immunoregulation in Multiple Sclerosis
Yang, L., Anderson, D. E., Kuchroo, J. R., & Hafler, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4409 · Cited by 142
Grossman, Z., Feinberg, M. B., & Paul, W. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6314 · Cited by 132
T Cell Responses to Human Endogenous Retroviruses in HIV-1 Infection
Garrison, K. E., Jones, R. B., Meiklejohn, D. A., Anwar, N., Ndhlovu, L. C., Chapman, J. M., Erickson, A. L., Agrawal, A., Spotts, G., Hecht, F. M., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030165 · Cited by 131
Self-citationAnderson, A. C., & Anderson, D. E. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.09.009 · Cited by 117
Andersson, J., Behbahani, H., Lieberman, J., Connick, E., LANDAY, A. L., Patterson, B. K., Sönnerborg, A. B., Loré, K., Uccinif, S., & Fehniger, T. E. (1999) · AIDS · doi:10.1097/00002030-199907300-00005 · Cited by 116
HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication
Hess, C., Altfeld, M. A., Thomas, S. Y., Addo, M. M., Rosenberg, E. S., Allen, T. M., Draenert, R., Eldrige, R. L., van Lunzen, J., Stellbrink, H. J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15735-8 · Cited by 111
Roos, M. T. L., van Lier, R. A. W., Hamann, D., Knol, G. J., Verhoofstad, I., van Baarle, D., Miedema, F. F., & Schellekens, P. T. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315737 · Cited by 101
Ostrowski, M., Justement, J. S., Ehler, L. A., Mizell, S. B., Lui, S., Mican, J., Walker, B. D., Thomas, E. K., Seder, R. A., & Fauci, A. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6133 · Cited by 90
Self-citationWang, C., Wen, T., Routy, J., Bernard, N. F., Sékaly, R., & Watts, T. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8252 · Cited by 81
Shacklett, B. L., Cox, C. A., Quigley, M. F., Kreis, C., Stollman, N., Jacobson, M. A., Andersson, J., Sandberg, J. K., & Nixon, D. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.641 · Cited by 72
Self-citationCombadière, B., Blanc, C., Li, T., Carcelain, G., Delaugerre, C., Cálvez, V., Tubiana, R., Debré, P., Katlama, C., & Autran, B. (2000) · European Journal of Immunology · Cited by 55
HIV-Induced Changes in T Cell Signaling Pathways
Schweneker, M., Favre, D., Martin, J. N., Deeks, S. G., & McCune, J. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6490 · Cited by 47
Self-citationThe impact of HIV on naïve T-cell homeostasis
Grossman, Z., & Paul, W. E. (2000) · Nature Medicine · doi:10.1038/79667 · Cited by 44
Skewed maturation of virus-specific CTLs?
Gamadia, L. E., ten Berge, I. J. M., Picker, L. J., & van Lier, R. A. W. (2002) · Nature Immunology · doi:10.1038/ni0302-203 · Cited by 22
Cited by
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
McLane, L. M., Abdel-Hakeem, M. S., & Wherry, E. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055318 · Cited by 1,975
Fraietta, J. A., Lacey, S. F., Orlando, E. J., Pruteanu-Malinici, I., Gohil, M., Lundh, S., Boesteanu, A. C., Wang, Y., O’Connor, R. S., Hwang, W.-T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0010-1 · Cited by 1,785
Fourcade, J., Sun, Z., Benallaoua, M., Guillaume, P., Luescher, I. F., Sander, C., Kirkwood, J. M., Kuchroo, V., & Zarour, H. M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100637 · Cited by 1,307
Metadata
- Authors
- Jones, R. B., Ndhlovu, L. C., Barbour, J. D., Sheth, P. M., Jha, A. R., Long, B. R., Wong, J. C., Satkunarajah, M., Schweneker, M., Chapman, J. M., Gyenes, G., Vali, B., Hyrcza, M. D., Yue, F. Y., Kovacs, C., Sassi, A., Loutfy, M., Halpenny, R., Persad, D., Spotts, G., Hecht, F. M., Chun, T.-W., McCune, J. M., Kaul, R., Rini, J. M., Nixon, D. F., & Ostrowski, M. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-11-10
- Volume
- 205
- Issue
- 12
- Pages
- 2763-2779
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2145476394
- Cited by
- 753
- References
- 50
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.